OTLK icon

Outlook Therapeutics

81 hedge funds and large institutions have $6.11M invested in Outlook Therapeutics in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$106K
2 +$60.4K
3 +$57K
4
BlackRock
BlackRock
New York
+$39.3K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$29.8K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$14K
27
$13.5K
28
$13.3K
29
$13K
30
$11.9K
31
$11.2K
32
$11.1K
33
$10.3K
34
$8.09K
35
$8K
36
$7.56K
37
$7.56K
38
$6.82K
39
$6.63K
40
$6.25K
41
$6.19K
42
$6K
43
$5.44K
44
$5.24K
45
$5K
46
$5K
47
$4.86K
48
$4.75K
49
$4.45K
50
$4K